MOVING LIFE SCIENCE INNOVATIONS
FROM DISCOVERY TO DEVELOPMENT TO DELIVERY
OUR VISION OF THE FUTURE: Arizona is a top-ten life science state.
OUR MISSION: AZBio supports the needs of Arizona’s growing life science ecosystem.
OUR MEMBERS: AZBio Members make an impact. They discover, develop and deliver health innovations including medicines, medical devices, diagnostics, and a wide range of health technologies. Our members also include economic development partners, educators, investors, leading business and philanthropic organizations, and patient advocacy organizations. AZBio Members employ over 365,000 Arizonans who are working together to make life better for people in Arizona and around the world.
Our industry sector generated over $43.64 billion in Economic Impact in 2023.
That's up over 88% from 2016 and growing at a Compound Annual Growth Rate of 9.5%.
Arizona’s bioscience industry (not including our hospitals) employed 40,399 in 2023 across 3,652 state business establishments, representing a rapid 24.6 percent increase in employment since 2019 and placing the state among the leaders in employment growth. The average wage in the bioscience industry was $102,161—53 percent higher than the state’s private sector average. View More of Arizona's Bioscience Industry Data
IN THE LOOP
AZBio In The Loop is your opportunity to stay up to date on what is happening across Arizona's Life Science and Healthcare Community.
SubscribeAZBio Members Are Making LIFE Better
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry.
AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona's life science sector. As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed.
AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations.
Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and medtech community.
Success Stories – Good News from Arizona’s BioIndustry
Building the Life Sciences Workforce of the Future
The Life Sciences Workforce Collaborative (LSWC) launched its first LSWC Best Workforce Strategies Roundtable on January 30, 2026 with opening remarks from Caitlin Frazer, Executive Director of the National Security Commission on Emerging Biotechnology (NSCEB).
Tracking U.S. Biopharma Investment: New Resources Detail State-by-State Impact
America’s biopharmaceutical sector is delivering unprecedented economic impact across the nation. Since January 2025, companies have committed more than $582 billion to bolster U.S. research and development, expand manufacturing and create jobs in communities nationwide.From cutting-edge manufacturing facilities in the South to next-generation research hubs in the Mid-Atlantic, the life sciences industry is driving local economic […]
Breakthru Medicine emerges from stealth with $60M Series A for cancer drug development
Phoenix, AZ, January 29, 2026 (Globe Newswire): Breakthru Medicine emerges from stealth mode with the close of a $60M Series A financing round following a prior undisclosed seed round. Breakthru was founded by biotech industry veterans Steve Potts, PhD, Mark Mulvihill, PhD, and Brian Barnett, MD, to deliver disruptive therapeutic modalities to cancer patients to address […]
BioLab Holdings Announces Investment in Advanced Synthetic Antimicrobial -Tissue Regeneration Solutions
PHOENIX, Jan. 27, 2026 /PRNewswire/ — BioLab Holdings, Inc., a Phoenix‑based medical manufacturer specializing in advanced wound protection technologies, has announced a strategic investment in Imbed Biosciences, Inc., the Wisconsin‑based medical device innovator behind the fully-synthetic SAM™ Antimicrobial Technology, and Microlyte®, the wound matrix based on SAM™ Technology.
Events
- OBBB - New Rules for Charitable Giving
        Feb 3, 2026 - - AZBio Day at The Capitol
        Feb 18, 2026 - Phoenix - Unleashing the full power of microarrays
        Feb 24, 2026 - - 2026 Flinn Bio Capital Conference
        Mar 5, 2026 - Phoenix - Rare Skeletal Conditions Advocacy Day at the Arizona Capitol
        Mar 16, 2026 - Phoenix











































































